← Open Payments lookup

SAMANTHA GRIFFIN: Open Payments

NPI 1952852568 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$269 in 13 payments from 7 companies in 2025. Trend: 2023 $905 · 2024 $272 · 2025 $269

Food & beverage: $269
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$68
ABBVIE INC.3$62
Madrigal Pharmaceuticals2$42
Janssen Biotech, Inc.2$38
Braintree Laboratories, Inc.1$21
GENZYME CORPORATION1$20
Gilead Sciences, Inc.1$18

Products named: XIFAXAN, REZDIFFRA, RINVOQ, TREMFYA, MAVYRET, SUTAB, DUPIXENT.

Industry payments across OR — which companies pay providers there.